Perawatan Regenera Activa @ Klinik REGENSIFY

It depends on each case: age, concomitant diseases, and genetic factors... as Androgenetic Alopecia (AGA) is a multifactorial condition. Microscopically, a significant reduction in the number of miniaturized hairs can be observed within three months. By the fourth month, changes in the quality and number of hairs are visible to the naked eye, as well as a high hair density. It is important to stress the importance of diagnosing AGA as the cause of hair loss for the protocol to be effective.

Depending on your hair condition at the point of treatment, it is quite common to have some shedding in the first few weeks after a Regenera Activa treatment. The treatment uses micro-grafts to stimulate hair follicle regeneration. This process pushes some hairs into a resting (telogen) phase, which can cause increased shedding in the first 2–8 weeks. It’s usually a temporary “shedding phase” similar to what happens with minoxidil or PRP treatments.

After Regenera Activa® treatment (autologous cell micrografting for hair loss), it’s important to give your scalp time to heal and let the regenerative process take effect. Here’s what you should avoid after the procedure:

🚫 Things to Avoid After Regenera Activa

1. Washing your hair too soon
   Avoid washing for at least 12–24 hours (follow your doctor’s exact advice). Use only gentle, mild shampoo when you resume washing.
2. Scratching, rubbing, or massaging the scalp
   Can disturb the micrografts and increase infection risk.
3. Excessive sun exposure / tanning
   Avoid direct sunlight and UV exposure on your scalp for about 1–2 weeks. Wear a hat if going outdoors.
4. Swimming (pool, sea, hot tub)
   Avoid for at least 7–10 days to prevent infection and irritation.
5. Intense exercise or heavy sweating
   Refrain from strenuous activity for 48–72 hours to reduce inflammation and risk of infection.
6. Hair treatments
   Avoid coloring, perming, bleaching, keratin, or chemical treatments for at least 2–3 weeks.
7. Alcohol & smoking
   Both can impair healing and reduce treatment effectiveness; best to avoid for a week or more.
8. Anti-inflammatory medications (NSAIDs, steroids) unless prescribed
   They may interfere with the body’s natural regenerative response.

✅ Good to do:

• Sleep with head slightly elevated for the first night if there’s swelling.
• Keep the scalp clean and protected.
• Follow your doctor’s post-care instructions closely.

Poor results can be observed when androgenetic alopecia courses with very few miniaturized hairs or when the onset or progression of the signs is extremely fast. We may also obtain scarce results when treating a scalp undergoing an inflammation process or with concomitant pathologies such as effluviums. For this reason, diagnosis is essential.

The diagnosis is essential, as indicated by the protocol. AMT® has only proved efficacy on the AGA kind of alopecia. For this reason, it is important to know whether your patient’s AGA is accompanied by another pathology such as telogen effluvium, an inflamed scalp or another pathology, since it can fully affect the success of the procedure. It is relevant not to have advanced evolutionary alopecia, as well as a normal blood test.

It is under these conditions that the AMT® can help to slow down the evolution of androgenetic alopecia in a biological way.

The procedure has no complications if performed under sterile conditions and strictly complies with the protocol, since it is an autologous (tissue from the same patient) and homologous (tissue from the same embryonical origin) micrografting procedure. AMT® stands out for being a minimally invasive and fast procedure that takes no more than 30 minutes to perform.

One of the main advantages of the AMT® procedure is its low invasiveness, which allows a quick recovery in about 24-48 hours, during which the patient is not allowed to wet the donor area.

The AMT® procedure is a highly quick intervention, lasting about 20-25 minutes each and results can last over 3 years.

With the AMT® procedure doctors obtain a micrograft solution that comes from skin biopsies that have the same embryological origin as the receptor site (homologous), meaning that the pathways activated with this procedure are much more specific than in a PRP treatment. Moreover, unlike PRP, the AMT® procedure generates a solution which contains not only growth factors, but also progenitor cells that remain in the patient’s scalp. Those cells will be continuously delivering cytokines, chemokines and growth factors to enhance regenerative properties of the affected area, for years. As a result, the healing will be much more efficient, and the results will be better and last longer.

The procedure with AMT® Protocol on AGA consists of a seeding of complete grafts of follicular units; meaning, for example, that the first capillary line can be advanced only if there are hair follicles with small diameter and density. It is important to note that AMT® Protocol has the potential to "nourish" the damaged area, since micro-grafts provide biological/molecular tools so that the cells themselves within the affected area can regenerate tissue and save hair follicles from miniaturization. 

Yes, indeed, its inflammation-modulating and neovascularisation-generating action makes it easier for the hair graft to survive, for the same reason it can rescue follicles in regression. Moreover, the antioxidant properties of the AMT® Solution help in the survival of extracted grafts during a hair transplant procedure, while helping the healing process of the donor site.  

AMT® can be useful in all stages of an AGA process in different ways. In an initial stage, it can be used as a preventive immunotherapy procedure thanks to the numerous cytokines, chemokines and growth factors that will nourish hair follicles. In mild-moderate stages, it can be useful in combination with other therapies to help rescuing hair follicles in severe states of miniaturization. In advanced stages of AGA, it can be used in combination with a hair transplant, to both accelerate healing and enhance the success rate of transplanted UFCs.

Being AMT® procedure on AGA Management an autologous and homologous procedure, it can be combined with any therapy, without any risks of cross-over reaction, since the whole process is done with cells from the own patient and saline solution, with no extra chemicals added.